Stopping Wegovy After 3 Months: What Actually Happens

Step 1: Understand where you are in the treatment process at three months

Three months into Wegovy, most people are somewhere in the middle of the titration schedule. Treatment begins at 0.25 mg and moves up through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose. Each step typically takes around four weeks, so at the twelve-week mark many patients are still on a dose lower than maintenance. This matters because the evidence for semaglutide's weight-management effects (around 15% average body-weight reduction in the STEP 1 trial, as published in the New England Journal of Medicine) is based on participants who completed the full 68-week programme. Stopping early means you are leaving before the dose that drove those results has had time to work fully.

Side effects are also most pronounced in the first weeks of treatment or after a dose increase, when nausea and digestive discomfort are most likely. Some people consider stopping at this point precisely because the early experience is unpleasant. That is understandable. But for many, those symptoms settle within a couple of weeks, and discontinuing during this window means missing the period when tolerability typically improves. It is worth telling your prescriber what you are experiencing before making a decision based on side effects alone.

Step 2: Weigh up what the evidence says about early discontinuation

The clinical picture around stopping semaglutide is fairly consistent. Once you stop taking it, appetite regulation reverts. The NHS medicine information for semaglutide makes clear that weight-management medicines like Wegovy are intended to be used alongside long-term lifestyle changes, not as a short course. Real-world data from the STEP 1 extension study found that participants who stopped semaglutide regained roughly two-thirds of their lost weight within a year — and some markers of metabolic health also returned towards baseline. Three months in, weight loss is usually still progressing. Stopping now locks in only a fraction of the potential benefit, and that fraction tends to reduce over the months that follow.

None of this means you must continue regardless of how you feel. There are legitimate reasons to stop or pause: a planned pregnancy, a surgical procedure requiring a washout, intolerable side effects that have been escalated and not resolved, or a prescriber's clinical judgement that the medicine is not suitable. Those are all valid. The point is that stopping because progress feels slow, or because the first few months were uncomfortable, is rarely the best outcome when an alternative plan exists. Our detailed guide to what to expect at the three-month mark covers the typical progress curve in more depth.

Step 3: Talk to your prescriber before you stop

If you are thinking about stopping Wegovy after three months, the most useful step is a conversation with the clinician responsible for your care. This applies whether you are considering stopping permanently, pausing for a period, or switching approaches. A prescriber can review your current weight trajectory, any side effects you have had, and whether a dose adjustment or a brief pause makes more sense than stopping outright. At nume, a named GPhC-registered prescriber personally reviews every patient's situation, nobody's consultation sits in a bot's queue. If you have a concern about how treatment is going at three months, our support team is available seven days a week and can route you to a clinical review.

For context on what continuing beyond this point typically looks like, our page on progress at six months sets out the evidence on sustained treatment, and for those still deciding whether Wegovy is the right fit, the Wegovy overview covers eligibility and the broader treatment picture. If cost is part of the reason you are weighing up whether to continue, our transparent guide to Wegovy pricing explains exactly what is included in private treatment. Every repeat order at nume is clinically re-reviewed; there is no subscription that rolls on without anyone checking.

If you do stop: what to expect and how to do it safely

If you and your prescriber agree that stopping is the right decision, the process itself is straightforward. Semaglutide is not physically addictive and does not require a formal taper in the way some medicines do, your prescriber will advise on whether any gradual reduction is appropriate given your current dose and circumstances. The main thing to be prepared for is a return of appetite. For most people this is gradual over days to a few weeks rather than immediate, but planning for it matters. Prioritising protein, maintaining the activity habits built during treatment, and staying in contact with your care team gives the best chance of preserving the progress made.

It is also worth knowing that stopping now does not close the door permanently. People who stop and later want to restart can do so following a fresh clinical assessment, as long as there is no clinical reason not to. If you stopped early due to side effects, a prescriber may want to reassess the dose at which to restart. The semaglutide information page covers the licensed indications and what clinical assessment involves. And if you are still at an early stage and wondering whether one month in is too soon to judge the medicine, the guide on stopping after one month addresses that question directly.